Molecular Pathology of Neuroblastic Tumors Based on Genome-wide Expression Analysis

  • William L. Gerald
Part of the Pediatric Oncology book series (PEDIATRICO)


Neuroblastic Tumor Neural Crest Development Comprehensive Gene Expression MYCN Expression MYCN mRNA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alaminos M, Mora J, Cheung NK et al. (2003) Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res 63:4538–4546PubMedGoogle Scholar
  2. Alvarado CS, London WB, Look AT et al. (2000) Natural history and biology of stage A neuroblastoma: a pediatric oncology group study. J Pediatr Hematol Oncol 22:197–205CrossRefPubMedGoogle Scholar
  3. Ambros PF, Ambros IM, Strehl S et al. (1995) Regression and progression in neuroblastoma: Does genetics predict tumor behavior? Eur J Cancer 31A:510–515CrossRefPubMedGoogle Scholar
  4. Boon K, Caron HN, van Asperen R et al. (2001) N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J 20:1383–1393CrossRefPubMedGoogle Scholar
  5. Brodeur GM, Maris JM (2002) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 4th edn. Lippincott Williams and Wilkins, Philadelphia, pp 761–797Google Scholar
  6. Brodeur GM, Seeger RC, Schwab M et al. (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stages. Science 224:1121–1124PubMedGoogle Scholar
  7. Chang NS, Mattison J, Cao H et al. (1998) Cloning and characterization of a novel transforming growth factor-beta 1 induced TIAF1 protein that inhibits tumor necrosis factor cytotoxicity. Biochem Biophys Res Commun 253:743–749CrossRefPubMedGoogle Scholar
  8. Choi LMR, Kim NW, Zuo JJ et al. (2000) Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med Pediatr Oncol 35:647–650CrossRefPubMedGoogle Scholar
  9. D'Angio GJ, Evans AE, Koop CE (1971) Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1:1046–1049CrossRefPubMedGoogle Scholar
  10. George RE, Kenyon RM, McGuckin AG et al. (1996) Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. Oncogene 12:1583–1587PubMedGoogle Scholar
  11. Grosfeld JL, Rescorla FJ, West KW et al. (1993) Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome. Semin Pediatr Surg 2:37–46PubMedGoogle Scholar
  12. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, Richter J, Rubin GM, Blake JA, Bult C, Dolan M, Drabkin H, Eppig JT, Hill DP, Ni L, Ringwald M, Balakrishnan R, Cherry JM, Christie KR, Costanzo MC, Dwight SS, Engel S, Fisk DG, Hirschman JE, Hong EL, Nash RS, Sethuraman A, Theesfeld CL, Botstein D, Dolinski K, Feierbach B, Berardini T, Mundodi S, Rhee SY, Apweiler R, Barrell D, Camon E, Dimmer E, Lee V, Chisholm R, Gaudet P, Kibbe W, Kishore R, Schwarz EM, Sternberg P, Gwinn M, Hannick L, Wortman J, Berriman M, Wood V, de la Cruz N, Tonellato P, Jaiswal P, Seigfried T, White R; Gene Ontology Consortium (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258–D261CrossRefPubMedGoogle Scholar
  13. Hiemstra JL, Schneider SS, Brodeur GM (1994) High-resolution mapping of the N-myc amplicon core domain in neuroblastomas. Prog Clin Biol Res 385:51–57PubMedGoogle Scholar
  14. Hiyama E, Hiyama K, Nishiyama M et al. (2003) Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity. J Pediatr Surg 38:1730–1734CrossRefPubMedGoogle Scholar
  15. Kushner B, Cheung NK, LaQuaglia M et al. (1996) Survival from locally invasive or metastatic neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373–381PubMedGoogle Scholar
  16. Ladanyi M, Gerald WL (2003) Expression profiling of human tumors; diagnostic and research applications. Humana Press, Totowa, New JerseyGoogle Scholar
  17. Li Y, Kang J, Horwitz MS (1998) Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 18:1601–10PubMedGoogle Scholar
  18. Look AT, Hayes FA, Shuster JJ et al. (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 9:581–591PubMedGoogle Scholar
  19. Ma A, Moroy T, Collum R et al. (1993) DNA binding by N-and L-Myc proteins. Oncogene 8:1093–1098PubMedGoogle Scholar
  20. Matthay KK, Perez C, Seeger RC et al. (1998) Successful treatment of stage III neuroblastoma based on prospective biologic staging: a children's cancer group study. J Clin Oncol 16:1256–1264PubMedGoogle Scholar
  21. Mora J, Cheung NK, Kushner BH et al. (2000) Loss of heterozygosity on chromosome arm 1p correlates with clinical categories of neuroblastoma. J Mol Diagn 2:37–46PubMedGoogle Scholar
  22. Nisen PD, Waber PG, Rich MA et al. (1988) N-myc oncogene RNA expression in neuroblastoma. J Natl Cancer Inst 80:1633–1637PubMedGoogle Scholar
  23. Ohira M, Morhashi A, Nakamura Y et al. (2003) Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma. Cancer Lett 197:63–68CrossRefPubMedGoogle Scholar
  24. Perez CA, Matthay KK, Atkinson JB et al. (2000) Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol 18:18–26PubMedGoogle Scholar
  25. Quackenbush J (2001) Computational analysis of microarray data. Nat Rev Genet 2:418–427CrossRefPubMedGoogle Scholar
  26. Ramaswamy S, Golub TR (2002) DNA microarrays in clinical oncology. J Clin Oncol 20:1932–1941PubMedGoogle Scholar
  27. Rust C, Karnitz LM, Paya CV et al. (2000) The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 275:20210–20216CrossRefPubMedGoogle Scholar
  28. Seeger RC, Brodeur GM, Sather H et al. (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111–1116PubMedGoogle Scholar
  29. Slavc I, Ellenbogen R, Jung WH et al. (1990) myc gene amplification and expression in primary human neuroblastomas. Cancer Res 50:1459–1463PubMedGoogle Scholar
  30. Su WT, Alaminos M, Mora J, Cheung NK, La Quaglia MP, Gerald WL (2004) Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas. Cancer Genet Cytogenet 154:131–137CrossRefPubMedGoogle Scholar
  31. Sweeney KJ, Clark GD, Prokscha A et al. (2000) Lissencephaly associated mutations suggest a requirement for the PAFAH1B heterotrimeric complex in brain development. Mech Dev 92:263–271CrossRefPubMedGoogle Scholar
  32. Van Limpt V, Chan A, Caron H et al. (2000) SAGE analysis of neuroblastoma reveals a high expression of the human homologue of the Drosophila Delta gene. Med Pediatr Oncol 35:554–558CrossRefPubMedGoogle Scholar
  33. Van Limpt VAE, Chan AJ, van Sluis PG et al. (2003) High delta-like expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int J Cancer 105:61–69CrossRefPubMedGoogle Scholar
  34. Wulf P, Bernhardt RR, Suter U (1999) Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res 57:467–478CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • William L. Gerald

There are no affiliations available

Personalised recommendations